1 / 27

Case of the Week

Case of the Week. Prof. V.O.L. Karusseit Dr. M.M. de Beer. Gerrie van Tonder. Age: 35years (DOB – 1972/06/01) Sex: Male Race: White Marital Status: Single Language: Afrikaans Occupation: Telephone Technician Residence: Rustenburg.

bishop
Download Presentation

Case of the Week

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Case of the Week Prof. V.O.L. Karusseit Dr. M.M. de Beer

  2. Gerrie van Tonder Age: 35years (DOB – 1972/06/01) Sex: Male Race: White Marital Status: Single Language: Afrikaans Occupation: Telephone Technician Residence: Rustenburg

  3. Patient presented at SOPD as a referral from his private GP with: • One year history of intermittent diarrhoea • Diarrhoea previously contained no blood but changed in the last week to dark red stools • No abdominal pain • Nausea and vomiting for the last week • Weight loss of five kilograms over the last six months

  4. Medical History: Hypertension Current Medication: Bisoprolol Prexium Surgical History: Procedure done for osteomeilitus of left leg in 1986 Allergies: None known Social History: Ten pack years of smoking, moderate whiskey drinker Family History: Mother had bone cancer (? Primary/metastatic)

  5. Special investigations Imaging: • CXR: No abnormalities • CT upper abdomen and pelvis: • Conclusion: liver is obviously non-homogeneous with several round, low-density areas in the liver • Metastatic until proven otherwise • Abnormal appearance in region of the caecum

  6. Differential diagnosis ?

  7. Tip: • On specific questioning the patient admits to hot flushes • Also experiences intermittent spells of breathlessness coupled with broncho-spasms.

  8. Laboratory Results: • Biochemical tests: within normal limits • Tumour markers: VMA slightly raised • 5-HIAA 24 hr urine collection: Increased Colonoscopy: • Large, lobulated mass in the caecum/ascending colon junction • Small polyp in transverse colon

  9. Biopsy result: • Carcinoid (adenocarcinoid or so-called “goblet cell” carcinoid • Liver biopsy – metastatic spread of carcinoid

  10. Patient is being followed up on an out-patient basis as well as at chemo-therapy.

  11. CARCINOID SYNDROME

  12. Carcinoids • Neuro-endocrine tumours of the gastrointestinal tract (carcinoids) are rare tumours • They originate in the enterochromaffin cells of the intestine and have the ability to produce various peptides and hormones. • Previously categorised by their embryological origin – foregut, midgut & hindgut. • Revised classification has taken into account tumour location, histological grade and proliferative index

  13. Carcinoid Syndrome • Carcinoid syndrome is almost uniquely associated with midgut carcinoids (neuro-endocrine tumours of the gastrointestinal tract) • Carcinoid syndrome was first described by Thorson and co-workers in 1954 • Systemic symptoms are caused by an excess of biogenic amines, peptides and other factors (serotonin, tachy- and bradykinins and histamine) in the circulation only after liver metasteses

  14. Symptoms • Diarrhoea (±80% of patients), mainly caused by serotonin excess, also histamine, kallikrein, prostaglandin, substance P and motilin • Flushing(± 94% ), linked to several humoral factors – tachykinins, serotonin & histamine. Provoked by e.g. nuts & cheese, certain drugs & alcohol • Carcinoid heart disease (± 40% ), characterised by so-called ‘plaques’ at the right side of the heart with involvement of the tricuspid and pulmonary valves and endocardium • Pellagra (± 5% ) characterised by dermatitis, diarrhoea & dementia – result of niacin deficiency • Intermittent bronchial obstruction (10%) often accompanies flushing, underlying mechanism not clear • Carcinoid crisis – rare, potentially fatal – provoked by anaesthesia / surgery if not treated sufficiently with somatostatin analogues

  15. Clinical Presentation • Carcinoid tumours less than 1cm in diameter & confined to the mucosa and submucosa generally remain subclinical for years. • Larger than 1 cm – generally malignant & have metastisized to regional lymph nodes and later to the liver and other locations. • Patients have generally been complaining for years of intermittent abdominal discomfort, erroneously diagnosed as a functional disorder such as irritable bowel. • Intermittent intestinal obstruction due to kinking of the small bowel can occur at a later stage as a result of the desmoplastic reaction in the mesentery

  16. Epidemiology • Incidence of midgut (neuro-)endocrine tumours is ± 0.2-2/100 000 population/year • Equal distribution between males & females • Incidence is higher in black than white people • Most prevalent location is the terminal ileum close to the ileocaecal valve • Is often multiple • In up to 15% of patients other malignancies such as gastrointestinal adenocarcinoma and breast cancer have been demonstrated

  17. Diagnostic procedures • Biochemical diagnosis includes measurements of serum chromogranin A and urinary excretion of 5-HIAA. Estimation of plasma serotonin is facultative • Tumour imaging - transabdominal ultrasound is the initial imaging procedure in most patients with metastised carcinoids. • Contrast-enhanced three-phase CT or MRI followed by needle biopsy for pathology can be performed. • In-pentetreotide scintigraphy is positive in 80-90% of patients • Echocardiography is mandatory in patients with carcinoid heart disease

  18. Prognosis • The prognosis of carcinoids arising in the distal jejunum and ileum is generally unfavourable compared to duodenal, gastric and rectal carcinoids – often lead to metasteses to adjacent lymph nodes, liver • 10 year survival rate – 43%, more favourable if the primary tumour has been removed and metasteses are absent. • Hepatic metasteses are frequent in patients with midgut carcinoid tumours (25-90%), 5-year survival rate = 0 – 50%

  19. Therapy • Surgical and interventional therapy • Medical therapy • Biotherapy • Somatostatin analogues • Interferon-A • Systemic chemotherapy • Radioligand therapy

More Related